MGTX
MeiraGTx Holdings plc
Halal Rating :
Last Price
$6.28
Last updated:
Market Cap
-
7D Change
6.26%
1 Year Change
-4.7%
Company Overview
Industries
Exchange
Next Earnings Date
MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. The company develops novel gene therapy treatments for ocular, neurodegenerative, and salivary gland diseases. Their pipeline includes treatments for inherited retinal diseases, xerostomia, and Parkinson's disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $10.91m | $54.31m | - | $3.36m | 0.00% | 6.18% |
| June 30, 2024 | $282000.0 | $49.45m | - | $3.25m | 0.00% | 6.58% |
| March 31, 2024 | $697000.0 | $50.72m | - | $3.25m | 0.00% | 6.41% |
Company Impact
Help us evaluate MeiraGTx Holdings plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.